Organigram Holdings Beheer

Beheer criteriumcontroles 4/4

De CEO Organigram Holdings is Beena Goldenberg, benoemd in Sep2021, heeft een ambtstermijn van 3.17 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 721.58K, bestaande uit 71.5% salaris en 28.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.044% van de aandelen van het bedrijf, ter waarde CA$ 101.90K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.2 jaar en 4.3 jaar.

Belangrijke informatie

Beena Goldenberg

Algemeen directeur

CA$721.6k

Totale compensatie

Percentage CEO-salaris	71.5%
Dienstverband CEO	3.2yrs
Eigendom CEO	0.04%
Management gemiddelde ambtstermijn	3.2yrs
Gemiddelde ambtstermijn bestuur	4.3yrs

Recente managementupdates

Recent updates

Organigram Holdings Inc.'s (TSE:OGI) P/S Is On The Mark

Jun 09

OrganiGram Holdings Inc. (TSE:OGI) Analysts Are Reducing Their Forecasts For This Year

Apr 18

What Did OrganiGram Holdings' (TSE:OGI) CEO Take Home Last Year?

Feb 12

Analysts Are More Bearish On OrganiGram Holdings Inc. (TSE:OGI) Than They Used To Be

Jan 14

Analyse CEO-vergoeding

Hoe is Beena Goldenberg's beloning veranderd ten opzichte van Organigram Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2023	CA$722k	CA$516k	-CA$229m
May 31 2023	n/a	n/a	-CA$222m
Feb 28 2023	n/a	n/a	-CA$11m
Nov 30 2022	n/a	n/a	-CA$8m
Aug 31 2022	CA$2m	CA$441k	-CA$14m

Compensatie versus markt: De totale vergoeding ($USD 516.24K ) Beena } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 722.42K ).

Compensatie versus inkomsten: De vergoeding van Beena is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Beena Goldenberg (60 yo)

3.2yrs

Tenure

CA$721,577

Compensatie

Ms. Beena G. Goldenberg, ICD D, has been Chief Executive Officer of OrganiGram Holdings Inc. since September 9, 2021 and as its Director since November 19, 2021. Ms. Goldenberg has been Independent Directo...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Beena Goldenberg	CEO & Director	3.2yrs	CA$721.58k	0.044% CA$ 101.9k
Helen Martin	Chief Legal Officer & Corporate Secretary	5.7yrs	CA$422.59k	0.023% CA$ 52.7k
Timothy Emberg	Chief Commercial Officer	2.1yrs	CA$429.42k	0.022% CA$ 50.9k
Paolo De Luca	Chief Strategy Officer	less than a year	CA$418.95k	0.023% CA$ 52.7k
Greg Guyatt	Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Nathalie Batten	Senior Vice President of Operations	3.4yrs	geen gegevens	geen gegevens
Geoff Riggs	Chief Information Officer	2.3yrs	geen gegevens	geen gegevens
Max Schwartz	Director of Investor Relations	no data	geen gegevens	geen gegevens
Megan McCrae	Senior Vice President of Marketing & Communications	3.5yrs	geen gegevens	0.011% CA$ 25.9k
Katrina McFadden	Chief People Officer	2.3yrs	geen gegevens	0.015% CA$ 34.3k
Gregory Engel	Special Advisor	3.5yrs	CA$893.95k	geen gegevens
Larry Rogers	Vice President of International Business Development	7.1yrs	CA$222.73k	geen gegevens

3.2yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van OGI wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Beena Goldenberg	CEO & Director	3yrs	CA$721.58k	0.044% CA$ 101.9k
Marjorie Wieshofer	Independent Director	3.8yrs	CA$167.50k	0.0023% CA$ 5.4k
Peter Amirault	Independent Chairman	8.4yrs	CA$236.92k	0.037% CA$ 86.0k
Stephen Smith	Independent Director	4.8yrs	CA$176.88k	0.0024% CA$ 5.5k
D. Machum	Independent Director	4.8yrs	CA$173.75k	0.0010% CA$ 2.4k
Dexter D. John	Independent Director	5.9yrs	CA$180.00k	0.0014% CA$ 3.3k
Sherry Porter	Independent Director	5.9yrs	CA$173.75k	0.0045% CA$ 10.5k
Craig Edward Harris	Director	less than a year	geen gegevens	geen gegevens
Simon Ashton	Independent Director	2.8yrs	geen gegevens	geen gegevens
Karina Gehring	Director	less than a year	geen gegevens	geen gegevens

4.3yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van OGI wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).

Organigram Holdings Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Organigram Holdings Inc., Annual General Meeting, Jan 22, 2025

Organigram Announces Appointment of Craig Harris to Board of Directors

Organigram Holdings Inc. Appoints Karina Gehring as Director and Announces Composition of Committees

Organigram Holdings Inc Announces Chief Financial Officer Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. Announces CFO Changes

Recent updates

Organigram Holdings Inc., Annual General Meeting, Jan 22, 2025

Organigram Holdings Inc. to Report Q3, 2024 Results on Aug 13, 2024

Organigram Announces Appointment of Craig Harris to Board of Directors

Organigram Holdings Inc. to Report Q2, 2024 Results on May 14, 2024

Organigram Holdings Inc. has completed a Composite Units Offering in the amount of CAD 25.0002 million.

Organigram Holdings Inc. Receives Health Canada’S Final Redetermination on Jolts

Organigram Holdings Inc. to Report Q1, 2024 Results on Feb 13, 2024

Organigram Holdings Inc. Appoints Karina Gehring as Director and Announces Composition of Committees

Organigram Holdings Inc Announces Chief Financial Officer Changes

Organigram Holdings Inc. to Report Q4, 2023 Results on Dec 19, 2023

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. announced that it expects to receive CAD 124.559674 million in funding from British American Tobacco p.l.c.

Organigram Holdings Inc., Annual General Meeting, Jan 15, 2024

Organigram Holdings Inc. Announces Resignation of Ms. Caroline Ferland as Board Member

Organigram Holdings Inc. Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower

Organigram Relaunches One of Canada's First Cannabis Brands, Trailblazer

Organigram Holdings Inc. Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes

Organigram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

Organigram Holdings Inc. to Report Q3, 2023 Results on Jul 13, 2023

Organigram Completes Share Consolidation to Ensure the Company Continues to Comply with Nasdaq Listing Requirements

New major risk - Shareholder dilution

Organigram Holdings Inc.'s (TSE:OGI) P/S Is On The Mark

Price target decreased by 12% to CA$1.50

Consensus EPS estimates increase from loss to CA$0.0029 profit

Consensus EPS estimates upgraded to CA$0.0012 loss, revenue downgraded

Price target decreased by 16% to CA$1.70

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Organigram Holdings Receives Non-Compliance Notice from Nasdaq

Consensus forecasts updated

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal 2023

Price target decreased to CA$2.07

Organigram Holdings Inc. to Report Q1, 2023 Results on Jan 12, 2023

Organigram Holdings Inc., Annual General Meeting, Feb 28, 2023

Price target decreased to CA$2.25

Consensus forecasts updated

Price target decreased to CA$2.30

OrganiGram Holdings Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended August 31, 2022

Organigram Holdings Inc. Launches Holy Mountain to Further Support Its Strong Position in the Dried Flower and Hash Categories

OrganiGram Holdings Inc. to Report Q4, 2022 Results on Nov 28, 2022

High number of new directors

Forecast to breakeven in 2025

Consensus estimates of losses per share improve by 31%

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of Fiscal Year 2022

Price target decreased to CA$2.73

OrganiGram Holdings Inc. to Report Q3, 2022 Results on Jul 14, 2022

Organigram Holdings Inc. Reaches Proposed Settlement

High number of new directors

Consensus EPS estimates fall by 24%

Second quarter 2022 earnings: Revenues in line with analyst expectations

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of Fiscal Year 2022

OrganiGram Holdings Inc. to Report Q2, 2022 Results on Apr 12, 2022

No longer forecast to breakeven

Consensus estimates of losses per share improve by 32%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter of Fiscal 2022

No longer forecast to breakeven

OrganiGram Holdings Inc. (TSX:OGI) acquired Laurentian Organic Inc. for CAD 35.9 million.

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Price target decreased to CA$3.59

OrganiGram Holdings Inc. Provides Revenue Guidance for the First Quarter of 2022

Organigram Holdings Inc Announces the Launch of SHRED’ems

Organigram Holdings Inc.Launches Cannabis Innovators Panel

Third quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.51 loss in 3Q 2020)

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2021

Organigram Launches Big Bag o’ Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format

OrganiGram Holdings Inc. (TSE:OGI) Analysts Are Reducing Their Forecasts For This Year

Second quarter 2021 earnings released: CA$0.28 loss per share (vs CA$0.041 loss in 2Q 2020)